Skip to content

iNOVA4Health - Advancing Precision Medicine

Menu
Banner
  • About Us
    • Mission
    • Collaborations
    • Partners
    • Management Board
    • Scientific Advisory Board
    • Careers
    • Contacts
  • Infrastructure
    • BioPilot Plant
    • GMP Analytical Services
    • GenIbet
    • NOVA-CRU
    • NIMSB Technology Platforms
  • Thematic Lines
    • TL1: Neurological and Vision Disorders
    • TL2: Cardio-Metabolic Disorders
    • TL3: Cancer
  • Research Groups
    • RG 1: Cell Bioprocesses for Advanced Therapies
    • RG 2: Molecular Biomarkers and Diagnosis
    • RG 3: Process Engineering for Biopharmaceuticals
    • RG 4: Protein Structure and Function in Biomedicine
    • RG 5: Health Function of Natural Bioactive Molecules
    • RG 6: Retinal Ageing and Disease
    • RG 7: Neuro-Inflammation
    • RG 8: Stroke and Neuroprotection
    • RG 9: Neurophysiology and Degeneration
    • RG10: Cardio-Vascular Diseases
    • RG11: Reno-Vascular Diseases
    • RG12: Diobesity
    • RG13: Musculoskeletal Immune-Regulation
    • RG14: Cell Metabolism and Cancer
    • RG15: Hepatobiliary and Pancreatic Cancer
    • RG16: Familial and Individual Cancer Risk
    • RG17: From Tumour Biology to Cancer Therapies
  • Highlights
  • Intranet

Search form

Partners

  • iBET logo
  • ITQB logo
  • NOVA Medical School logo
  • IPO logo
  • nimbs logo

News

  • “Engineering the tumor cell niche to study dormancy and drug resistance in metastatic breast cancer”

    12/06/2025

    iNOVA4Health Seminar by Shreyas Rao

  • iNOVA4Health (i4H) Unveils New Institutional Video

    21/10/2024

    i4H is embarking on a transformative journey over the next five years. With a renewed strategic approach and governance structure in place, we remain committed to advancing precision medicine through pioneering translational initiatives.

  • "The Story of a Biotech Startup Bringing Innovation to Market"

    17/10/2024

    iNOVA4Health Seminar by Alain Bernard

Events

  • iNOVA4Health Seminar - Engineering the Tumor Cell Niche to Study Dormancy and Drug Resistance in Metastatic Breast Cancer

    06 Jun 25

    By Shreyas S Rao

  • iNOVA4Health Seminar - Tuned Microbial Expression Systems for Highly Engineered Biologics

    04 Apr 25

    By Thomas Sauer and Daniel Degreif

  • iNOVA4Health Seminar - Process Analytical Utility of Raman Microscopy for Cell Therapy Manufacturing

    17 Mar 25

    By James Piret

Publications

  • Identification of germline FOXE1 and somatic MAPK pathway gene alterations in patients with malignant struma ovarii, cleft palate and thyroid cancer

    2024 / Pires C, Saramago A, Moura MM, Li J, Donato S, Marques IJ, Belo H, Machado AC, Cabrera R, Grünewald TGP, Leite V, Cavaco BM

    more info

  • Interaction between NSCLC cells, CD8+ T-cells and immune checkpoint inhibitors potentiates coagulation and promotes metabolic remodeling-new cues on CAT-VTE

    2024 / Freitas-Dias C, Gonçalves F, Martins F, Lemos I, Gonçalves LG, Serpa J

    more info

  • H2S-synthesizing enzymes are putative determinants in lung cancer management toward personalized medicine

    2024 / Hipólito A, Mendes C, Martins F, Lemos I, Francisco I, Cunha F, Almodovar T, Albuquerque C, Gonçalves LG, Bonifácio V, Vicente JB, Serpa J

    more info

© Copyright 2025 iNOVA4HEALTH